This site is updated Hourly Every Day

Trending Featured Popular Today, Right Now

Colorado's Only Reliable Source for Daily News @ Marijuana, Psychedelics & more...

Post: Making progress in reducing veteran suicide rates

Picture of Anschutz Medical Campus

Anschutz Medical Campus

AnschutzMedicalCampus.com is an independent website not associated or affiliated with CU Anschutz Medical Campus, CU, or Fitzsimons innovation campus.

Recent Posts

Anschutz Medical Campus

Making progress in reducing veteran suicide rates
Facebook
X
LinkedIn
WhatsApp
Telegram
Threads
Email

According to the Department of Veterans Affairs and Centers for Disease Control and Prevention, the suicide rate among veterans is nearly 60% higher than the general population. It is one of the leading causes of deaths among veterans under the age of 45. Post-traumatic stress disorder being left untreated or mistreated adds to the problem. PTSD leads to overwhelming feelings of hopelessness, emotional numbness and isolation. These are directly linked to suicidal ideation. Flashbacks, nightmares, hypervigilance, anger and avoidance behaviors severely disrupt daily functioning, further exacerbating depression and making recovery feel impossible. Self-medicating with substances like alcohol or drugs — common for those suffering — can further compound the issue.

A broad stroke of traditional medication and talk therapy is not enough to combat the complexities involved in this crisis. Often when addressing PTSD and other mental health related treatments, heavy pharmaceuticals will be applied. This method is rife with dangerous drug side-effects coinciding with the risk of reliance and addiction to a drug not specifically adept at correcting the misfiring brain chemistry. It can be a “wet-blanket” effect, leaving patients feeling empty or zombie-like while simply going through the motions of life.

Emerging treatments such as psychedelics are being explored with comprehensive medical evaluation as long-term recovery options. Ibogaine is one example. Derived from the African plant Tabernanthe iboga, ibogaine has been studied for its potential to alleviate symptoms of PTSD, depression and anxiety. Recent research indicates that ibogaine can effectively reduce those symptoms in veterans with traumatic brain injuries.

Treatments via ibogaine interact with multiple neurotransmitter systems, including serotonin, dopamine and glutamate, while modulating N-methyl-D-aspartate (NMDA) receptors and promoting neuroplasticity. This neuroplasticity is the key to “resetting” natural pathways. They are repairable, but not via typical pharmaceuticals. Trauma and triggering events disrupt brain activity to the point of reliving the events over and over, causing deeper damage with the sufferer stuck in a loop of intrusive thoughts and memories. This can lead to a stasis of emotional numbing that makes actual healing more difficult. Restoration is key to long-term recovery.

When a heavy-duty benzodiazepine is introduced (and often over-proscribed), the ultimate […]

Leave a Reply

Your email address will not be published. Required fields are marked *

You Might Be Interested...

Microdosing 101

Microdosing 101

Kate Schroeder LPC, LMHC, NCC Key points Microdosing should be approached thoughtfully with proper research and guidance. A trained facilitator can help ensure an individual’s

Read More »